A trial to evaluate a best practice cardiogenic shock care pathway vs standard care on equity and patient outcomes in Cardiogenic Shock:

Not Applicable

• Conditions: Cardiogenic shock; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12623001140640
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-03
• Last Update Posted: 13 November 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

1. Inpatients at least 18 years of age at any location within a participating centre.
2. Diagnosed with CS, defined as:
a. ST elevation myocardial infarction (STEMI) OR current/recent (within 12 months) evidence of left ventricular dysfunction
AND
b. At least 2 of:
i. systolic blood pressure less than 90mmHg;
ii. use of an inotrope or vasopressor to maintain systolic blood pressure greater than, or equal to, 90mmHg
iii. serum lactate greater than 3mmol/L.

Exclusion Criteria

1. Terminal non-cardiac condition or advanced care directive rendering advanced cardiac and/or life support therapies inappropriate
2. Inpatients being managed with palliative intent
3. Evidence of established anoxic brain injury
4. Established non-cardiac cause of shock (eg. sepsis, haemorrhagic shock, anaphylactic shock).
5. Transferred from a non-participating institution with an established CS diagnosis.
6. Out-of-hospital cardiac arrest with ongoing cardiopulmonary resuscitation (including ECMO-CPR).

Study & Design

• Study Type: Interventional
• Study Design: Not specified